102 related articles for article (PubMed ID: 9679941)
1. Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Droller MJ
J Urol; 1998 Aug; 160(2):620-1. PubMed ID: 9679941
[No Abstract] [Full Text] [Related]
2. Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Belair CD; Yeager TR; Lopez PM; Reznikoff CA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13677-82. PubMed ID: 9391085
[TBL] [Abstract][Full Text] [Related]
3. Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Günes C; Wezel F; Southgate J; Bolenz C
Nat Rev Urol; 2018 Jun; 15(6):386-393. PubMed ID: 29599449
[TBL] [Abstract][Full Text] [Related]
4. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
[TBL] [Abstract][Full Text] [Related]
5. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
[TBL] [Abstract][Full Text] [Related]
6. Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
Selli C; Gelmini S; Scott CA; Crisci A; Giannarini G; Orlando C
Urology; 2000 Aug; 56(2):331. PubMed ID: 10925114
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in human urothelial tumors.
Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase immunoreactivity in human bladder carcinoma.
Shochina M; Fellig Y; Sughayer M; Pizov G; Vitner K; Podeh D; Hochberg A; Ariel I
Mol Pathol; 2001 Aug; 54(4):248-52. PubMed ID: 11477140
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y
J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Yang SC; Lee DH; Hong SJ; Chung BH; Kim IY
Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
[TBL] [Abstract][Full Text] [Related]
12. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
De Kok JB; Schalken JA; Aalders TW; Ruers TJ; Willems HL; Swinkels DW
Int J Cancer; 2000 Jul; 87(2):217-20. PubMed ID: 10861477
[TBL] [Abstract][Full Text] [Related]
14. Galactosyl transferase in benign and neoplastic human bladder mucosa.
Hagen-Cook K; Prout GR; Plotkin GM; Gilbert SL; Wolf G
Surg Forum; 1978; 29():627-9. PubMed ID: 122622
[No Abstract] [Full Text] [Related]
15. Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.
Maitra A; Rathi A; Gazdar AF; Sagalowsky A; Ashfaq R
Cancer; 2001 Feb; 93(1):73-9. PubMed ID: 11241269
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
17. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Borah S; Xi L; Zaug AJ; Powell NM; Dancik GM; Cohen SB; Costello JC; Theodorescu D; Cech TR
Science; 2015 Feb; 347(6225):1006-10. PubMed ID: 25722414
[TBL] [Abstract][Full Text] [Related]
18. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.
Kömhoff M; Guan Y; Shappell HW; Davis L; Jack G; Shyr Y; Koch MO; Shappell SB; Breyer MD
Am J Pathol; 2000 Jul; 157(1):29-35. PubMed ID: 10880372
[TBL] [Abstract][Full Text] [Related]
20. Integrin-linked kinase functions as a tumor promoter in bladder transitional cell carcinoma.
Wang DL; Lan JH; Chen L; Huang B; Li Z; Zhao XM; Ma Q; Sheng X; Li WB; Tang WX
Asian Pac J Cancer Prev; 2012; 13(6):2799-806. PubMed ID: 22938462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
